Michigan-based HistoSonics is about $51,000 shy of closing a $14.2 million funding round in support of its non-invasive tissue ablation technology. Michigan medical device maker HistoSonics is creeping toward the close of a $14.22 million funding round in support of its non-invasive tissue ablation technology. The company has raised about $14.17 million so far from 13 unnamed investors, through sales of equity, options, warrants and other rights to acquire securities, according to an SEC filing dated May 16.
Help employers find you! Check out all the jobs and post your resume.
